Argenx Se ARGX
NASDAQ ARGX
$1,039.24 -14.21 (-1.35%)
As of: Sep 4, 2026 · 11:44 AM EDT

Argenx Se (ARGX) Gross Margin (2022 - 2026)

Argenx Se's (ARGX) quarterly Gross Margin came in at 90.68% in Q2 2026, up 236.0% YoY from 26.99% in Q2 2025, and little changed on a QoQ basis from 90.68% in Q1 2026.

Analysis

Argenx Se (ARGX) Gross Margin (2022 - 2026) Analysis & Trends

Argenx Se (ARGX) has 5 years of Gross Margin data on file, last reported at 90.68% in Q2 2026.

  • Quarterly Gross Margin rose 236.0% year-over-year to 90.68% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 90.03% (up 64.0% YoY) and the FY2025 annual result came in at 89.39%, down 52.0% from the prior year.
  • Gross Margin was little changed at 90.68% in Q2 2026, from 90.68% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 93.52% in Q1 2022 to a low of 88.33% in Q2 2025.
  • A 5-year average of 90.5% and a median of 90.22% in 2024 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2023 — Gross Margin tumbled 317 bps — and 2026, when it soared 236 bps.
  • Tracing ARGX's Gross Margin over 5 years: stood at 92.63% in 2022, then slipped by 3 bps to 89.45% in 2023, then gained by 1 bps to 90.14% in 2024, then dropped by 2 bps to 88.36% in 2025, then gained by 3 bps to 90.68% in 2026.
  • The last three Gross Margin figures came in at 90.68% (Q2 2026), 90.68% (Q1 2026), and 88.36% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 91.59%
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 90.43%
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn 35.86%
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 89.76%
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 76.90%
8 Royalty Pharma 28.63 Bn 27.79 Bn - -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn 84.20%
10 Incyte 25.60 Bn 21.07 Bn 1.57 Bn 93.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.43%
Mar 31, 2026 90.68%
Dec 31, 2025 88.36%
Sep 30, 2025 90.29%
Jun 30, 2025 88.33%
Mar 31, 2025 89.75%
Dec 31, 2024 90.14%
Sep 30, 2024 89.69%
Jun 30, 2024 89.03%
Mar 31, 2024 89.16%
Dec 31, 2023 89.45%
Sep 30, 2023 89.06%
Jun 30, 2023 91.08%
Mar 31, 2023 91.59%
Dec 31, 2022 92.63%
Sep 30, 2022 92.18%
Jun 30, 2022 93.31%
Mar 31, 2022 93.52%